NASDAQ:CTMX
CytomX Therapeutics Stock News
$1.98
-0.0600 (-2.94%)
At Close: May 10, 2024
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CytomX Therapeutics, Inc. (NASDAQ: CTMX) between May 17, 2018, and May 13, 2020, inclusive (the "Class Period
LOS ANGELES, CA / ACCESSWIRE / June 22, 2020 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against CytomX Therapeutics, Inc. ("C
CLASS ACTION UPDATE for CTMX, ENDP and CEMI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
06:45pm, Monday, 22'nd Jun 2020
NEW YORK, NY / ACCESSWIRE / June 22, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders
NEW YORK, NY / ACCESSWIRE / June 22, 2020 / Pomerantz LLP announces that a class action lawsuit has been filed against CytomX Therapeutics Inc. ("CytomX" or the "Company") (CTMX) and certain of its of
New York, New York--(Newsfile Corp. - June 22, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in CytomX Therapeutics, Inc. (NASDAQ: CTMX) ("CytomX" or the "Com
The electronic poster #4551 titled “Preclinical characterization of novel anti-CTLA-4 prodrug antibodies with an enhanced therapeutic index” was presented as part of the Therapeutic Antibodies 3 S
Two Sigma Investments LP Sells 131,777 Shares of CytomX Therapeutics Inc (NASDAQ:CTMX)
08:02am, Monday, 22'nd Jun 2020
Two Sigma Investments LP lessened its holdings in shares of CytomX Therapeutics Inc (NASDAQ:CTMX) by 42.4% in the first quarter, according to its most recent disclosure with the Securities & Exchange
Lawsuits Filed Against HALL, CTMX and SRNE - Jakubowitz Law Pursues Shareholders Claims
05:20am, Monday, 22'nd Jun 2020
NEW YORK, NY / ACCESSWIRE / June 22, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who
Pomerantz LLP announces that a class action lawsuit has been filed against CytomX Therapeutics Inc. (“CytomX” or the “Company”) (CTMX) and certain of its officers. The class action, filed in
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CTMX, CCL and WFC
09:15pm, Friday, 19'th Jun 2020
NEW YORK, NY / ACCESSWIRE / June 19, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. S
NEW YORK, NY / ACCESSWIRE / June 19, 2020 / Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CytomX Therapeutics, Inc. (NASDAQ:CTMX) between May 17, 2018, and
New York, New York--(Newsfile Corp. - June 19, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Cy
BidaskClub Upgrades CytomX Therapeutics (NASDAQ:CTMX) to “Buy”
01:28am, Friday, 19'th Jun 2020
CytomX Therapeutics (NASDAQ:CTMX) was upgraded by equities research analysts at BidaskClub from a “hold” rating to a “buy” rating in a research note issued on Friday, BidAskClub reports. Sever
Is CytomX Therapeutics (CTMX) Stock Outpacing Its Medical Peers This Year?
03:30pm, Thursday, 18'th Jun 2020
Is (CTMX) Outperforming Other Medical Stocks This Year?
